In the past 10 years, Tumor immunotherapy technology has been a major development, and gradually applied to clinical trials. As one of the hopes of the ultimate capture of the tumor, immunotherapy has become a hot topic in this field.
The conference was successfully held in Beijing from March 29 to 31, with academicians from the field of biologics at home and abroad, industry leaders and other executives attended the event. Including precision medicine and gene therapy, stem cell technology and stem cell therapy, tumor immunotherapy, eight major topics were discussed in depth.
As the first domestic supplier of cell analysis products, Countstar was invited to attend the meeting. At the meeting Countstar shows you the Countstar cell counter, Countstar fluorescent cell analyzer and other products, attracting many new and old customers.